Terms: = Brain cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
9 results:
1. An immunosuppressed microenvironment distinguishes lateral ventricle-contacting glioblastomas.
Bartkowiak T; Lima SM; Hayes MJ; Mistry AM; Brockman AA; Sinnaeve J; Leelatian N; Roe CE; Mobley BC; Chotai S; Weaver KD; Thompson RC; Chambless LB; Ihrie RA; Irish JM
JCI Insight; 2023 Jun; 8(12):. PubMed ID: 37192001
[TBL] [Abstract] [Full Text] [Related]
2. Mortality Associated With Mental Disorders and Comorbid General Medical Conditions.
Momen NC; Plana-Ripoll O; Agerbo E; Christensen MK; Iburg KM; Laursen TM; Mortensen PB; Pedersen CB; Prior A; Weye N; McGrath JJ
JAMA Psychiatry; 2022 May; 79(5):444-453. PubMed ID: 35353141
[TBL] [Abstract] [Full Text] [Related]
3. Racial Disparities Affecting Postoperative Outcomes After brain Tumor Resection.
Thomas G; Almeida ND; Mast G; Quigley R; Almeida NC; Amdur RL; Moss A; Mahfuz A; Sherman JH
World Neurosurg; 2021 Nov; 155():e665-e673. PubMed ID: 34478887
[TBL] [Abstract] [Full Text] [Related]
4. Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies.
Menyhárt O; Fekete JT; Győrffy B
Carcinogenesis; 2021 Jun; 42(6):804-813. PubMed ID: 33754151
[TBL] [Abstract] [Full Text] [Related]
5. PU.1 drives specification of pluripotent stem cell-derived endothelial cells to LSEC-like cells.
De Smedt J; van Os EA; Talon I; Ghosh S; Toprakhisar B; Furtado Madeiro Da Costa R; Zaunz S; Vazquez MA; Boon R; Baatsen P; Smout A; Verhulst S; van Grunsven LA; Verfaillie CM
Cell Death Dis; 2021 Jan; 12(1):84. PubMed ID: 33446637
[TBL] [Abstract] [Full Text] [Related]
6. Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
Sahin A; Sanchez C; Bullain S; Waterman P; Weissleder R; Carter BS
PLoS One; 2018; 13(7):e0199414. PubMed ID: 29975720
[TBL] [Abstract] [Full Text] [Related]
7. Intraoperative MRI for the management of brain lesions adjacent to eloquent areas.
Reyns N; Leroy HA; Delmaire C; Derre B; Le-Rhun E; Lejeune JP
Neurochirurgie; 2017 Jun; 63(3):181-188. PubMed ID: 28571707
[TBL] [Abstract] [Full Text] [Related]
8. A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.
Dvorkina M; Nieddu V; Chakelam S; Pezzolo A; Cantilena S; Leite AP; Chayka O; Regad T; Pistorio A; Sementa AR; Virasami A; Barton J; Montano X; Lechertier T; Brindle N; Morgenstern D; Lebras M; Burns AJ; Saunders NJ; Hodivala-Dilke K; Bagella L; De The H; Anderson J; Sebire N; Pistoia V; Sala A; Salomoni P
Clin Cancer Res; 2016 Jul; 22(13):3398-409. PubMed ID: 27076624
[TBL] [Abstract] [Full Text] [Related]
9. Effective and economical option for pain palliation in prostate cancer with skeletal metastases: 32P therapy revisited.
Shah Syed GM; Maken RN; Muzzaffar N; Shah MA; Rana F
Nucl Med Commun; 1999 Aug; 20(8):697-702. PubMed ID: 10451877
[TBL] [Abstract] [Full Text] [Related]
